CClinicalTrials.gg
CompletedNCT05227443ET-fILDUpdated Feb 23, 2022

Effects of Exercise Training on Respiratory Performance in Patients With Fibrosing Interstitial Lung Diseases

An interventional study of Exercise aerobic training and Upper, lower and breathing (ULB) exercise in Lung Diseases, Interstitial Lung Disease and Fibrosis Lung, sponsored by Alexandria University. Completed at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-02-23.

Sponsored by Alexandria University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year 11 months after the study started (first participant enrolled Jan 2020, registered Dec 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
31
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The current study recruited patients with fibrosing interstitial lung diseases (f-ILD) whatever was the underlying pathology. The investigators aimed to compare the effects of aerobic exercises for lower limbs (LL) versus upper limbs, lower limbs, and breathing exercises (ULB) on the peak exercise measurements that was measured using cardiopulmonary exercise testing (CPET), dyspnea and health related quality of life assessment in this group of patients.

Read the detailed description

The investigators conducted a case-control study with a follow up after 6 weeks (short term). All the participants on recruited were evaluated clinically. A high resolution computed tomography (HRCT) scan of the chest was performed to confirm the diagnosis of f-ILD as well as a spirometry. All the patients were subjected to cardiopulmonary exercise testing (CPET), 6-minute walk test (6-MWT), evaluation of dyspnea using mMRC dyspnea scale, and evaluation of health related quality of life using St. George's Respiratory Questionnaire (SGRQ). The control group were followed up by telephone calls. The intervention groups (LL and ULB) were subjected randomly to aerobic exercise training for 6 weeks. After termination of all the session, the patients were re-evaluated clinically and objectively using CPET, 6-MWT, mMRC and SGRQ. Also, we evaluated the outcome of the patients (control and intervention groups) as those who died or reported exacerbation of the underlying disease were recorded.

02

Conditions studied

  • Lung Diseases
  • Interstitial Lung Disease
  • Fibrosis Lung
03

In context

Lung Diseases

3,303 studies on the registry are indexed under Lung Diseases; 355 are open to participants now.

This study's enrollment of 31 is below the median of 72 across 2,118 interventional studies indexed under Lung Diseases.

Browse Lung Diseases studies →

Lead sponsor

Alexandria University is the lead sponsor of 569 studies on the registry; 125 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adult patients aged ≥ 18 years.
  • Fibrosis interstitial lung diseases (f-ILDs) diagnosed based on HRCT radiological features.
  • Restrictive or mixed pattern in forced spirometry test

Exclusion criteria

Exclusion Criteria:

  • Motor disabilities
  • Cardiovascular diseases (as acute heart failure, unstable angina or recent myocardial infarction)
  • Cognitive impairments
  • History of cerebrovascular accident
  • Active cancer
  • Life expectancy less than 3 months.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
31 participants (actual)

Study arms

  • No intervention
    Control

    The control group did not receive exercise training and the participants were informed to complete their medications provided by the treating physician.

  • Active comparator
    Lower limb (LL) exercise training

    All the participants in this modality of training were subjected to only lower limbs aerobic exercise training.

    Procedure: Exercise aerobic training

  • Active comparator
    Upper, lower and breathing (ULB) exercise training

    All the participants in this modality of training were subjected to upper and lower limb aerobic exercise training as well as breathing training.

    Procedure: Upper, lower and breathing (ULB) exercise

Interventions

  • ProcedureExercise aerobic training

    It is a procedure that is in the form of exercise training as a part of rehabilitation. The patients were subjected to 3 supervised sessions of exercise training / week for a total duration of 6 weeks. The form of training was aerobic intensity exercise that lasts for 15 minutes of continuous exercise. In this intervention, the investigators provide only lower limbs training exercises.

    Also known as: Lower limbs (LL) training

  • ProcedureUpper, lower and breathing (ULB) exercise

    It is a procedure that is in the form of exercise training as a part of rehabilitation. The patients were subjected to 3 supervised sessions of exercise training / week for a total duration of 6 weeks. The form of training was aerobic intensity exercise that lasts for 15 minutes of continuous exercise. In this intervention, the investigators provide lower and upper limbs training exercises as well as breathing exercises.

06

What researchers measure

Primary outcomes

  1. Maximum oxygen consumption

    Cardiopulmonary exercise testing (CPET) was used to assess the improvement of maximum oxygen consumption.

    Time frame: 6 weeks

  2. Quality of life evaluation

    St. George's Respiratory Questionnaire (SGRQ) was used to assess the health related quality of life. SGRS constitutes 50 items and the score ranging from 0 to 100, with higher scores indicating more limitations.

    Time frame: 6 weeks

Secondary outcomes

  1. Dyspnea

    mMRC dyspnea scale (ranging from 0 (the best) - 4 ( the worst) was used to evaluate the improvement of dyspnea.

    Time frame: 6 weeks

  2. Resting oxygen saturation

    Pulse oximeter was used to assess the change in oxygen saturation (SaO2) at rest after termination of exercise sessions. SaO2 is presented as percentage (%).

    Time frame: 6 weeks

07

Study locations

1 site
  • Faculty of medicine, Alexandria University
    Alexandria, 21526, Egypt
08

References and documents

Individual participant data

Plan to share: Undecided — We are planning to share IPD but until now we did not decided as we need to talk with all the researchers conducted the trial before it is available for the public. For the time being, the data is available on request from the principal investigator.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 23, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05227443
Lead sponsor
Alexandria University
Responsible party
Hanaa Shafiek (Assistant professor, Alexandria University) — Principal investigator
First posted
Feb 7, 2022
Start date
Jan 16, 2020
Primary completion
Apr 30, 2021
Completion
Jul 30, 2021
Last update
Feb 23, 2022

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion